Literature DB >> 16391816

In vitro isolation of circulating endothelial progenitor cells is related to the high density lipoprotein plasma levels.

Fabio Pellegatta1, Marta Bragheri, Liliana Grigore, Sara Raselli, Franco Maria Maggi, Claudia Brambilla, Alice Reduzzi, Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano.   

Abstract

Circulating endothelial progenitor cells (EPCs) play an important role in post natal neovascularization. High density lipoproteins (HDL) protect the vascular wall from atherosclerosis. The role exerted by HDL on EPCs physiology is unknown. In this study we investigated whether the levels of plasma HDL can modulate the number of EPCs. The number of EPCs was evaluated in 24 subjects as the number of endothelial colony-forming unit (e-CFU) growth in culture. The number of AC133 positive progenitor cells present in the gate of the CD34 bright positive lymphocytes was also evaluated. Plasma levels of HDL, triglycerides and total cholesterol/HDL cholesterol ratio correlated with the number of e-CFU (r=0.62, P=0.006; r=-0.54, P=0.019, and r=-0.61, P=0.007 respectively), but not with the number of CD34/AC133 positive progenitor cells. In vitro, the incubation of the mononuclear cellular fraction with HDL did not increase the number of e-CFU in culture, whereas LDL and VLDL reduced the number of e-CFU. Our results indicate that human HDL plasma levels directly relate to the number of circulating endothelial progenitor cells that can be isolated in vitro, as determined by the number of e-CFU.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391816

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

1.  HDL and Endothelial Function.

Authors:  Yufei Wu; Yangkai Xu; Jie Chen; Mingming Zhao; Kerry-Anne Rye
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review.

Authors:  Paul Philipp Heinisch; Corina Bello; Maximilian Y Emmert; Thierry Carrel; Martina Dreßen; Jürgen Hörer; Bernhard Winkler; Markus M Luedi
Journal:  Cells       Date:  2022-05-18       Impact factor: 7.666

Review 3.  Progenitor cells and vascular disease.

Authors:  M Jevon; A Dorling; P I Hornick
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

4.  Endothelial progenitor cells and plaque burden in stented coronary artery segments: an optical coherence tomography study six months after elective PCI.

Authors:  Sylvia Otto; Kristina Nitsche; Christian Jung; Aleh Kryvanos; Andrey Zhylka; Kerstin Heitkamp; Juan-Luis Gutiérrez-Chico; Björn Goebel; P Christian Schulze; Hans R Figulla; Tudor C Poerner
Journal:  BMC Cardiovasc Disord       Date:  2017-04-26       Impact factor: 2.298

5.  Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.

Authors:  Ana Villegas; Fernando A Gonzalez; Leopoldo Llorente; Santiago Redondo
Journal:  Biologics       Date:  2008-09

6.  Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.

Authors:  Gavin Dreyer; Arthur T Tucker; Steven M Harwood; Rupert M Pearse; Martin J Raftery; Muhammad M Yaqoob
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.